Le Lézard5h
Novartis receives Health Canada approval for Fabhalta® oral treatment for adult patients with PNH
Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance for Fabhalta® (iptacopan capsules) as ...
Armed robbery in Revesby4h
FDA OKs Pfizer's ADCETRIS Combo for Relapsed Lymphoma
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...
What NOT to Do If You’re Bitten By a Brown Recluse
The name “brown recluse” conjures up nightmarish visuals for a majority of the population, and not only for those who have arachnophobia. This unique spider is found in 16 states, most of which are in ...
Next's digitally altered jeans advert has been banned - thank god
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
PipelineReview.com11h
U.S. FDA Approves Pfizer’s ADCETRIS® Combination Regimen for the treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NEW YORK, NY, USA I 12, 2025 I Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental ...
Le Lézard3h
Pfizer's TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate Cancer
Pfizer Inc. today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide ...
New Scientist3h
Most Europeans may have had dark skin until less than 3000 years ago
Ancient DNA from 348 individuals suggests that pale skin became the predominant characteristic of people living in Europe ...